These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15253274)

  • 1. Mammary tumor heterogeneity in wt-ErbB-2 transgenic mice.
    Kosanke S; Edgerton SM; Moore D; Yang X; Mason T; Alvarez K; Jones L; Kim A; Thor AD
    Comp Med; 2004 Jun; 54(3):280-7. PubMed ID: 15253274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice.
    Yang X; Edgerton SM; Kosanke SD; Mason TL; Alvarez KM; Liu N; Chatterton RT; Liu B; Wang Q; Kim A; Murthy S; Thor AD
    Cancer Res; 2003 May; 63(10):2425-33. PubMed ID: 12750262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice.
    Ritland SR; Rowse GJ; Chang Y; Gendler SJ
    Cancer Res; 1997 Aug; 57(16):3520-5. PubMed ID: 9270023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.
    Cadieux C; Kedinger V; Yao L; Vadnais C; Drossos M; Paquet M; Nepveu A
    Cancer Res; 2009 Sep; 69(18):7188-97. PubMed ID: 19738070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma.
    Wechselberger C; Strizzi L; Kenney N; Hirota M; Sun Y; Ebert A; Orozco O; Bianco C; Khan NI; Wallace-Jones B; Normanno N; Adkins H; Sanicola M; Salomon DS
    Oncogene; 2005 Jun; 24(25):4094-105. PubMed ID: 15897912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor-dependent activation of Gab1 is involved in ErbB-2-mediated mammary tumor progression.
    Gillgrass A; Cardiff RD; Sharan N; Kannan S; Muller WJ
    Oncogene; 2003 Dec; 22(57):9151-5. PubMed ID: 14668796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice.
    Henry MD; Triplett AA; Oh KB; Smith GH; Wagner KU
    Oncogene; 2004 Sep; 23(41):6980-5. PubMed ID: 15286714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.
    Liu JC; Deng T; Lehal RS; Kim J; Zacksenhaus E
    Cancer Res; 2007 Sep; 67(18):8671-81. PubMed ID: 17875707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenge with mammary tumor cells expressing MHC class II and CD80 prevents the development of spontaneously arising tumors in MMTV-neu transgenic mice.
    Jabrane-Ferrat N; Campbell MJ; Esserman LJ; Peterlin BM
    Cancer Gene Ther; 2006 Nov; 13(11):1002-10. PubMed ID: 16841083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice.
    Yamazaki M; Akahane T; Buck T; Yoshiji H; Gomez DE; Schoeffner DJ; Okajima E; Harris SR; Bunce OR; Thorgeirsson SS; Thorgeirsson UP
    Carcinogenesis; 2004 Sep; 25(9):1735-46. PubMed ID: 15166086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different gene-expression profiles for the poorly differentiated carcinoma and the highly differentiated papillary adenocarcinoma in mammary glands support distinct metabolic pathways.
    Eilon T; Barash I
    BMC Cancer; 2008 Sep; 8():270. PubMed ID: 18811984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis.
    Liu S; Liu W; Jakubczak JL; Erexson GL; Tindall KR; Chan R; Muller WJ; Adhya S; Garges S; Merlino G
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3770-5. PubMed ID: 11867754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.
    Jacquemart IC; Springs AE; Chen WY
    Int J Oncol; 2009 Feb; 34(2):517-28. PubMed ID: 19148488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Black cohosh increases metastatic mammary cancer in transgenic mice expressing c-erbB2.
    Davis VL; Jayo MJ; Ho A; Kotlarczyk MP; Hardy ML; Foster WG; Hughes CL
    Cancer Res; 2008 Oct; 68(20):8377-83. PubMed ID: 18922910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A direct test of potential roles for beta3 and beta5 integrins in growth and metastasis of murine mammary carcinomas.
    Taverna D; Crowley D; Connolly M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(22):10324-9. PubMed ID: 16288021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
    van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
    BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
    Blavier L; Lazaryev A; Dorey F; Shackleford GM; DeClerck YA
    Cancer Res; 2006 Mar; 66(5):2691-9. PubMed ID: 16510589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic alterations in the development of mammary and prostate cancer in the C3(1)/Tag transgenic mouse model.
    Yoshidome K; Shibata MA; Maroulakou IG; Liu ML; Jorcyk CL; Gold LG; Welch VN; Green JE
    Int J Oncol; 1998 Feb; 12(2):449-53. PubMed ID: 9458374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the silybin-phosphatidylcholine complex (IdB 1016) on the development of mammary tumors in HER-2/neu transgenic mice.
    Provinciali M; Papalini F; Orlando F; Pierpaoli S; Donnini A; Morazzoni P; Riva A; Smorlesi A
    Cancer Res; 2007 Mar; 67(5):2022-9. PubMed ID: 17332330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.